Health informatics

Hospital at Home Care Set to Make it Big in the United States with Strong Support from the Government

Monday, April 12, 2021 - 4:03pm

This model can extend hospital-grade care to a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure.

Key Points: 
  • This model can extend hospital-grade care to a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure.
  • "\nSavant added: "Home care was largely confined to low acuity services, but the availability of advanced remote monitoring and digital health solutions such as artificial intelligence (AI), computer vision, and robotics is causing a shift.
  • Further, remote monitoring and telehealth technologies are expected to witness a high growth rate of 35% to 40% with the major push coming from the home care segment.
  • Contact us: Start the discussion\n'

Hospital at Home Care Set to Make it Big in the United States with Strong Support from the Government

Monday, April 12, 2021 - 3:50pm

This model can extend hospital-grade care to a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure.

Key Points: 
  • This model can extend hospital-grade care to a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure.
  • "\nSavant added: "Home care was largely confined to low acuity services, but the availability of advanced remote monitoring and digital health solutions such as artificial intelligence (AI), computer vision, and robotics is causing a shift.
  • Further, remote monitoring and telehealth technologies are expected to witness a high growth rate of 35% to 40% with the major push coming from the home care segment.
  • Contact us: Start the discussion\n'

MyHomeDoc Ltd., Remote Personal Examination Solution Provider, has gained FDA 510(k) Class II Clearance For Its Innovative, Comprehensive, and Cost-Effective Device

Monday, April 12, 2021 - 2:00pm

b'RAANANA, Israel, April 12, 2021 /PRNewswire/ -- MyHomeDoc today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the MyHomeDoc system, which uses a multi-sensor device to remotely examine the mouth, throat, lungs, ears, heart, skin, abdomen, body temperature, and oxygen saturation (SpO2).\nThe device has been cleared for use in testing patients from 2 years old and older, making it suitable for a broad range of primary, chronic, and urgent care modalities for all demographics from pediatrics to seniors.\nIn a world where telehealth is becoming increasingly center stage, the shortcomings of the pre-existing model point to the need for a more seamless experience for everyone, which will make it possible for physicians to support their clinical decisions with clinically valid physical examination results.\nThe system utilizes a handheld device that pairs with a smartphone, user-friendly app, and includes a fully adaptable administration panel, best-in-class cybersecurity, and hybrid system architecture that integrates seamlessly with those of proprietary healthcare systems.\nIn addition, the system introduces multiple clinical workflows to connect patients and physicians with either offline (asynchronous) or online (synchronous) modes.\n"We are excited that this FDA clearancein conjunction with the CE mark that we received earlier this yearwill make it possible for more people to benefit from our user-friendly, cost-effective solution that elevates telehealth closer to the in-person clinic visit experience than ever before," says MyHomeDoc CEO Alon Natanson , "MyHomeDoc is an agent of change in the telehealth market enabling flexible business models based on innovative technology.

Key Points: 
  • b'RAANANA, Israel, April 12, 2021 /PRNewswire/ -- MyHomeDoc today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the MyHomeDoc system, which uses a multi-sensor device to remotely examine the mouth, throat, lungs, ears, heart, skin, abdomen, body temperature, and oxygen saturation (SpO2).\nThe device has been cleared for use in testing patients from 2 years old and older, making it suitable for a broad range of primary, chronic, and urgent care modalities for all demographics from pediatrics to seniors.\nIn a world where telehealth is becoming increasingly center stage, the shortcomings of the pre-existing model point to the need for a more seamless experience for everyone, which will make it possible for physicians to support their clinical decisions with clinically valid physical examination results.\nThe system utilizes a handheld device that pairs with a smartphone, user-friendly app, and includes a fully adaptable administration panel, best-in-class cybersecurity, and hybrid system architecture that integrates seamlessly with those of proprietary healthcare systems.\nIn addition, the system introduces multiple clinical workflows to connect patients and physicians with either offline (asynchronous) or online (synchronous) modes.\n"We are excited that this FDA clearancein conjunction with the CE mark that we received earlier this yearwill make it possible for more people to benefit from our user-friendly, cost-effective solution that elevates telehealth closer to the in-person clinic visit experience than ever before," says MyHomeDoc CEO Alon Natanson , "MyHomeDoc is an agent of change in the telehealth market enabling flexible business models based on innovative technology.
  • "\nThe systems will be available for commercial deployment in the United States by early May.\nMyHomeDoc is a fast-growing medical start-up, founded in 2016, with offices based in Israel (HQ) and the United States.
  • MyHomeDoc is dedicated to the democratization of primary, chronic and pediatric care within the community, and is pursuing that by introducing new digital enhancements and creating new opportunities for better patient care.\nYou can reach us for more details: info@homedoc-care.com .\nMyHomeDoc is participating this month in the #MEDinISRAEL2021 expo and ACP - Internal Medicine Meeting 2021, come see us at our virtual booth or schedule a time to learn how MyHomeDoc solution adds the dimension of medical-grade data to your video- or telephonic-based virtual care thereby elevating the telehealth experience closer to the in-clinic visit.\n'

Nerivio® Wearable Migraine Therapeutic Now Eligible for Insurance Coverage through UpScript's Telemedicine Platform

Monday, April 12, 2021 - 2:00pm

"We appreciate the efforts UpScript made to make Nerivio available and covered through its advanced telemedicine platform.

Key Points: 
  • "We appreciate the efforts UpScript made to make Nerivio available and covered through its advanced telemedicine platform.
  • People with migraine need rapid, affordable access to safe and effective therapies, and this is exactly what they can get using UpScript.
  • The Nerivio Patient Savings Program and reimbursement hub implementation enables Theranica to offer eligible patients with health insurance a co-pay as low as $10, depending on specific plan coverage.
  • The company\'s award-winning flagship product, Nerivio, is the first FDA-cleared smartphone-controlled prescription wearable device for acute treatment of migraine and has provided more than 100,000 treatments.

Global Clinical Decision Support Systems (CDSS) Markets, 2019-2020 & 2021-2030: Opportunities in the Integration of CDSS with Blockchain & Collaborations with Precision Medicine Providers

Friday, April 16, 2021 - 2:15pm

b'DUBLIN, April 16, 2021 /PRNewswire/ -- The "Global Clinical Decision Support Systems (CDSS) Market: Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com\'s offering.\nThe research report constitutes an in-depth study of the global CDSS market, including a thorough analysis of revenues generated from the use of CDSS in professional healthcare settings.\nBased on the product launches, approvals, and ongoing strategic collaborations, as well as business expansions, the market size and potential for the forecast period of 2021-2030 have been estimated.\nThe clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans.

Key Points: 
  • b'DUBLIN, April 16, 2021 /PRNewswire/ -- The "Global Clinical Decision Support Systems (CDSS) Market: Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com\'s offering.\nThe research report constitutes an in-depth study of the global CDSS market, including a thorough analysis of revenues generated from the use of CDSS in professional healthcare settings.\nBased on the product launches, approvals, and ongoing strategic collaborations, as well as business expansions, the market size and potential for the forecast period of 2021-2030 have been estimated.\nThe clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans.
  • Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate.\nThe technology is still in its nascent stage.
  • One of the strong points of this technology is that it improves with time.
  • Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes.\nKey Questions Answered in this Report:\nHow has COVID-19 impacted the adoption of CDSS as well as the market dynamics influencing it?\nWhat are the key regulations governing the CDSS market in key regions?\nWhat are the technological developments which are expected to have the maximum influence on the global CDSS market?\nWho are the leading players to hold significant dominance on the global CDSS market currently?\nWhat are the key business models being followed by the key players in the market?\nWhat are some of the major factors which are expected to influence the growth in adoption of CDSS across the globe?\nWhat are the key strategies incorporated by leading players in the global CDSS market landscape?\nWhat is the current revenue contribution for the different types of CDSS, and what are the expected modifications in the forecast period?\nWhich countries contribute to the major share of the current demand, and which ones hold significant scope for growth during the next 10 years?\n'

Medscape Physician Compensation Report Shows Salaries Held Steady, Despite Pandemic

Friday, April 16, 2021 - 11:05am

However, the combination of government pandemic relief programs, staff reductions, capitation plans which continued to pay physicians, and reimbursement for telemedicine visits blunted the impact.

Key Points: 
  • However, the combination of government pandemic relief programs, staff reductions, capitation plans which continued to pay physicians, and reimbursement for telemedicine visits blunted the impact.
  • "Our report shows that many were able to pivot to use telemedicine and focus on tactics that would protect their practices.
  • "\nThe 2021 Medscape Physician Compensation Survey was completed by 17,903 physicians representing 29 specialty areas, including Medscape members and nonmembers.
  • Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools.

Edison Investment Research Limited: Doctor Care Anywhere Group (DOC): Initiation - DOC from home

Friday, April 9, 2021 - 8:00am

Doctor Care Anywhere (DOC) is a fast-growing telehealth company focused on the private healthcare sector.

Key Points: 
  • Doctor Care Anywhere (DOC) is a fast-growing telehealth company focused on the private healthcare sector.
  • However, our two-year forecast revenue CAGR of 80% is 34% ahead of the peer group average 60% growth rate.
  • Click here to view the full report or here to sign up to receive research as it is published.
  • About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors.

AHN Grove City Implements Virtual ICU to Enhance Critical Care Services - State-of-the-art Telehealth ICU Model Keeps Patients Close to Home

Friday, April 9, 2021 - 5:00am

GROVE CITY, Pa., April 9, 2021 /PRNewswire-PRWeb/ --Seriously ill or injured patients of Allegheny Health Network's (AHN) Grove City Hospital may now have their critical care supported by an innovative telehealth solution.

Key Points: 
  • GROVE CITY, Pa., April 9, 2021 /PRNewswire-PRWeb/ --Seriously ill or injured patients of Allegheny Health Network's (AHN) Grove City Hospital may now have their critical care supported by an innovative telehealth solution.
  • The team uses the two-way high-definition camera to observe the patient or interact with the onsite clinicians at AHN Grove City about the patient's condition and plan of care.
  • "As a Level IV Trauma Center, AHN Grove City sees its share of patients who require critical care services," said Suzanne Labriola, DO, AHN physician consultant for the hospital.
  • AHN Grove City is a 67-bed acute care hospital in Mercer County, employing 300 health care professionals.

ResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021

Thursday, April 8, 2021 - 9:05pm

Please note that ResMed does not use outside phone lines to access the earnings call.

Key Points: 
  • Please note that ResMed does not use outside phone lines to access the earnings call.
  • A replay of the earnings webcast will be accessible on ResMeds website and available approximately two hours after the webcast.
  • Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases.
  • Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.

MinuteClinic Video Visit Telehealth Offering Now Available in Montana

Thursday, April 8, 2021 - 3:30pm

People in Montana can now seek care for non-emergency, routine health care through MinuteClinic Video Visits, a telehealth offering.

Key Points: 
  • People in Montana can now seek care for non-emergency, routine health care through MinuteClinic Video Visits, a telehealth offering.
  • Video Visits are available 24 hours a day, seven days a week, and can be accessed via a mobile device or computer.
  • While there are currently no physical MinuteClinic locations in Montana, MinuteClinic Video Visits provides state residents with convenient access to high quality care.
  • During a MinuteClinic Video Visit, the provider will assess the patient's condition and determine the appropriate course of treatment following evidence-based clinical care guidelines.